Effect of Hapushadi Yapan Basti and Kokilaksha Ksheerbasti in Vatrakta (~Gout) â?? Randomized control trial

Assessment of comparative efficacy of Hapushadi Yapan Basti versus Kokilaksha Ksheerbasti in the management of Vatrakta (~Gout) â?? Randomized control trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055056

Enrollment

Registered

2023-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient showing signs and symptoms of vatarakta (gouty arthritis) Age group between 20 to 70 years Patient willing for written consent Patient indicated for basti Patient with elevated uric acid level

Exclusion criteria

Exclusion criteria: Patients diagnosed with any other systemic illness which are fatal and chronic in nature Below 20 and above 70 years old patients Known case of ulcers or ulcerativecolitis Basti Ayogy(patient unfit for Basti chikitsa) Pregnant woman

Design outcomes

Primary

Measure	Time frame
Serum uric acid sign and symptoms of VatarakataTimepoint: 24 days with followup baseline and on 8th & 24th day	—

Secondary

Measure	Time frame
Sandhishoola (Pain in joints), . Sparshasahatva (Tenderness of joints) , Sandhidaha (Burning sensation in joints), Sandhigraha (stiffness in joints). Angavaikalya (Deformity of joints) Sr. uric acid Sandhishotha (joint circumference for assess swelling). Timepoint: 24 days with follow up basline and on 8th & 21th day	—

Countries

India

Contacts

Public ContactDr Sonwane Ramesh Dnyanoba

DMIMS, MGACH & RC Salod, Wardha, Maharashtra

dr.vinodade@gmail.com9689365368

Outcome results